Prescription opiate medications: medical uses and consequences, laws and controls.
The proposed analysis and evaluation of the data elements in the OPP and other similar regulatory programs will support the following potential impact on the patients and physicians in Michigan and other states: Reduced rates of addictive use of prescriptions of Schedule II medications. Reduced rates of addictive patterns of prescribing of Schedule II medications. Improved the prescribing of Schedule II medication for pain disorders. Improved the prescribing of Schedule II medications in addictive disorders. Establish the need and direction for development of curriculum for Schedule II drugs for undergraduate medical education and continuing medical education. Establish the need and direction for development of curriculum for use of Schedule II medications in patients with addictive and pain disorders. Explore the need and direction for development of the monitoring system medical curriculum for Schedule III, IV, and V drugs. Demonstrate link between diversion and adverse effects on health caused by an addictive pattern of use and prescribing of Schedule II drugs
Miller
Norman S
NS
Department of Psychiatry and Medicine, College of Human Medicine, Michigan State University, A227 East Fee Hall, East Lansing, MI 48824-1316, USA. norman.miller@hc.msu.edu
D039721:Diagnostic and Statistical Manual of Mental Disorders; D011307:Drug Prescriptions; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006291:Health Policy / Q000331:legislation & jurisprudence; D006801:Humans; D009294:Narcotics / Q000627:therapeutic use*; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000517:prevention & control*; D014481:United States
D009294:Narcotics